Levi & Korsinsky Notifies Joint Stock Company Kaspi.kz Investors of a Class Action Lawsuit and Upcoming Deadline – KSPI

NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=124731&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com […]

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Celanese Corporation Investors to Inquire About Securities Class Action Investigation – CE

NEW YORK, NY / ACCESS Newswire / January 23, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Celanese Corporation (NYSE:CE) resulting from allegations that Celanese may have issued materially misleading business information to the investing public. SO WHAT: If you

Levi & Korsinsky Announces an Investigation on Behalf of Universal Display Corporation (OLED) Shareholders Who May Have Been Affected by Fraud

NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Universal Display Corporation ("Universal Display Corporation") (NASDAQ:OLED) concerning possible violations of federal securities laws. On August 1, 2024, Universal reported solid 2Q 2024 results and raised the bottom-end of its full year

Rakuten Medical Announces Initiation of Global Phase 3 Trial of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for First-Line Recurrent Head and Neck Cancer

— First patient treated in the U.S. — Initial enrollment planned for the U.S., Japan, and Taiwan, with further expansion to additional countries and regions Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting Alluminox™ platform-based photoimmunotherapy, today announcedthe initiation of its global multi-regional Phase 3 clinical trial evaluating ASP-1929 photoimmunotherapy in

$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ZUO, BERY, AMCR, AUB to Act Now

(NYSE:ZUO),(NYSE:BERY),(NYSE:AMCR),(NYSE:AUB), NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating:

South Plains Financial, Inc. Declares Quarterly Cash Dividend

(NASDAQ:SPFI), LUBBOCK, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains”), the parent company of City Bank, today announced that its Board of Directors has declared a quarterly cash dividend of $0.15 per share of common stock. The dividend is payable on February 18, 2025 to shareholders of record as

Scroll to Top